論合成生物技術發(fā)明的可專利性
[Abstract]:Synthetic biology has been developing rapidly in recent years, which has attracted wide attention. Although the application of synthetic biology is still in the basic research stage, with the continuous development of synthetic biology, it will have a wider application prospect in the future. However, there are no laws and regulations related to synthetic biology in China, which may affect the development of synthetic biology in China in the future. In this context, the invention of synthetic biotechnology as the research object, first of all, mainly introduced the concept of synthetic biology and its current development; Secondly, the patent object of synthetic biotechnology invention is analyzed, in which the patent object is analyzed from the point of view of genome synthetic technology and biological printing technology. Then, select the core and most mature technology in synthetic biotechnology, the artificial synthesis of genomes, and discuss the patent nature of the technology from three aspects: novelty, creativity, and practicality. It combines the relevant laws and regulations of genetic engineering technology to carry on the analysis. Finally, some suggestions are put forward for the establishment of a patent system for synthetic biotechnology in China. From the point of view of the process of deepening reform, the process of opening up and expanding, and the requirements of economic development and scientific and technological progress in China, Especially in the face of the opportunities and challenges of the knowledge economy and the rapid development of synthetic biotechnology, the current situation of patent system construction and management of synthetic biotechnology in China is still very inadequate. So we should guide the sustainable development of synthetic biology and promote the progress of the whole society by constructing a patent system that conforms to the development of synthetic biotechnology.
【學位授予單位】:華中科技大學
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:D923.42
【參考文獻】
相關期刊論文 前10條
1 高莉;;基因序列專利正當性:美國論爭與啟示[J];揚州大學學報(人文社會科學版);2014年01期
2 肇旭;;Myriad案與基因專利的未來[J];河北法學;2014年01期
3 劉曉;熊燕;王方;趙國屏;;合成生物學倫理、法律與社會問題探討[J];生命科學;2012年11期
4 漆蘇;朱雪忠;;從 Mayo v. Prometheus案看美國“專利適格標的”判斷標準的變化[J];知識產(chǎn)權;2012年09期
5 呂靜;孫洪磊;何皓;傅鵬程;;合成生物學及其在生物技術中的應用進展[J];生物化學與生物物理進展;2012年02期
6 曹麗榮;;我國基因專利保護范圍界定的思考[J];河北法學;2010年12期
7 張春霆;;合成生物學研究的進展[J];中國科學基金;2009年02期
8 葉邦策;王建軍;;合成生物學與人工生命體[J];科學;2008年06期
9 趙學明;王慶昭;;合成生物學:學科基礎、研究進展與前景展望[J];前沿科學;2007年03期
10 張春霆;;合成生物學:我國急需發(fā)展的前沿科學[J];前沿科學;2007年03期
相關重要報紙文章 前2條
1 宋建寶;;美國:涉及DNA專利申請案的可專利性問題[N];人民法院報;2014年
2 張懿;;青蒿素“專利之痛”又將發(fā)作?[N];文匯報;2012年
相關碩士學位論文 前3條
1 吳素娟;論基因技術的專利保護[D];南京航空航天大學;2007年
2 楊大為;生物技術知識產(chǎn)權保護研究[D];東南大學;2005年
3 姜國鋒;高新技術領域知識產(chǎn)權保護與反壟斷[D];山東大學;2005年
,本文編號:2296232
本文鏈接:http://sikaile.net/falvlunwen/minfalunwen/2296232.html